SMS Pharmaceuticals galloped 13.9% to Rs 83.15 at 14:45 IST on BSE after the company announced successful inspection by Pharmaceuticals and Medical Devices Agency Japan Authorities, for the manufacturing facility in Hyderabad.
The announcement was made during market hours today, 23 August 2017.Meanwhile, the BSE Sensex was up 260.56 points, or 0.83%, to 31,552.41. Meanwhile, the BSE Small-Cap index was up 177.10 points, or 1.15%, to 15,565.72.
High volumes were witnessed on the counter. On the BSE, 57,869 shares were traded in the counter so far, compared with an average volume of 9,342 shares in the past one quarter. The stock had hit a high of Rs 85.10 and a low of Rs 73.95 so far during the day. The stock had hit a 52-week high of Rs 115 on 6 October 2016. The stock had hit a 52-week low of Rs 66.60 on 11 August 2017.
The stock had underperformed the market over the past one month till 22 August 2017, falling 10.98% compared with 2.3% decline in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 16% as against Sensex's 2.36% rise. The scrip had also underperformed the market in past one year, declining 21.08% as against Sensex's 11.81% rise.
The small-cap company has an equity capital of Rs 8.47 crore. Face value per share is Re 1.
SMS Pharmaceuticals announced the successful inspection by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities, for the manufacturing facility-unit II at Bachupally, Ranga Reddy district, Hyderabad, Telangana during the period from 25 to 27 July 2017.
The inspection was focused on general good manufacturing practices of the site. The inspection was concluded with no critical/major observations.
SMS Pharmaceuticals' net profit rose 10% to Rs 14.22 crore on 47% decline in net sales to Rs 83.34 crore in Q4 March 2017 over Q4 March 2016.
SMS Pharmaceuticals is a global player in active pharmaceutical ingredient (API) manufacturing.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
